<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药事纵横 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-20T07:18:46+08:00</updated>
  <subtitle>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！投稿请发442015666@qq.com</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020年FDA批准的新药总结（三）</title>
    <updated>2020-11-19T19:34:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/RlI8ygo0pfPzAWBIHITOjA</id>
    <link href="https://mp.weixin.qq.com/s/RlI8ygo0pfPzAWBIHITOjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>12月，高端社交盛宴再度来袭，制药大咖云集上海浦东，你准备好了么？</title>
    <updated>2020-11-19T19:34:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/w8sv5SxGDb8lyjIXrASAJg</id>
    <link href="https://mp.weixin.qq.com/s/w8sv5SxGDb8lyjIXrASAJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浅谈USP关于液相色谱柱的分类</title>
    <updated>2020-11-19T19:34:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/nrDAZmA8TG0upZaYBSbdJA</id>
    <link href="https://mp.weixin.qq.com/s/nrDAZmA8TG0upZaYBSbdJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年医保谈判大趋势与大猜想</title>
    <updated>2020-11-19T19:34:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/RQ5gl-o1z2az8cmf3bWj-Q</id>
    <link href="https://mp.weixin.qq.com/s/RQ5gl-o1z2az8cmf3bWj-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年中国批准新药（二）</title>
    <updated>2020-11-18T16:33:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/Qs1BbKx_SWoF9WVOy1Ajuw</id>
    <link href="https://mp.weixin.qq.com/s/Qs1BbKx_SWoF9WVOy1Ajuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安全！光可控！| CAR-T疗法安全性研究的最新进展</title>
    <updated>2020-11-18T16:33:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/vXNMRPZI_Rzc-y2d20eYlg</id>
    <link href="https://mp.weixin.qq.com/s/vXNMRPZI_Rzc-y2d20eYlg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关于刻痕片的思考</title>
    <updated>2020-11-18T16:33:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/5XOVNizEYkrrYiB62E_Vcg</id>
    <link href="https://mp.weixin.qq.com/s/5XOVNizEYkrrYiB62E_Vcg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药事纵横广告投放须知</title>
    <updated>2020-11-18T16:33:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/iNqYG7L_mbPp-TLYwIDnhA</id>
    <link href="https://mp.weixin.qq.com/s/iNqYG7L_mbPp-TLYwIDnhA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年中国批准Ⅰ类新药</title>
    <updated>2020-11-17T20:09:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/J5lSJI6M8iboclLUDndQIg</id>
    <link href="https://mp.weixin.qq.com/s/J5lSJI6M8iboclLUDndQIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>政策法规组合出击，药用辅料如何助力药品质量提升？</title>
    <updated>2020-11-17T20:09:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/aXU2cKmbFcqblkF8cENAmw</id>
    <link href="https://mp.weixin.qq.com/s/aXU2cKmbFcqblkF8cENAmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA数据简要分析：Accelerate Approval 篇</title>
    <updated>2020-11-17T20:09:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/Wg0IaR34t0kq8drKOMBlCg</id>
    <link href="https://mp.weixin.qq.com/s/Wg0IaR34t0kq8drKOMBlCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>USP药典新通则1467：残留溶剂方法确认与验证</title>
    <updated>2020-11-17T20:09:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/SNvZp27jraCQDWUwzNKMSA</id>
    <link href="https://mp.weixin.qq.com/s/SNvZp27jraCQDWUwzNKMSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从“非苏拉赞”再看抑酸新革命</title>
    <updated>2020-11-16T19:46:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Eo2bYgoEwZLryXF13NcdPQ</id>
    <link href="https://mp.weixin.qq.com/s/Eo2bYgoEwZLryXF13NcdPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【网络研讨班】2020药品冻干技术: 设备、原理、 工艺、优化及案例分析专题培训</title>
    <updated>2020-11-16T19:46:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/iopIM2fG8IxzyWpw6k9_RA</id>
    <link href="https://mp.weixin.qq.com/s/iopIM2fG8IxzyWpw6k9_RA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA对抗肿瘤仿制药BE豁免的观点及案例分析</title>
    <updated>2020-11-16T19:46:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/oYBcJBbQ09-adA11bOSL_A</id>
    <link href="https://mp.weixin.qq.com/s/oYBcJBbQ09-adA11bOSL_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>尼达尼布从发现到上市，不得不说的故事</title>
    <updated>2020-11-16T19:46:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/le3EdjH5kFwCSN24OyPBLg</id>
    <link href="https://mp.weixin.qq.com/s/le3EdjH5kFwCSN24OyPBLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GMP实操一：物料转代码</title>
    <updated>2020-11-15T19:47:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/xy9WjDonsUIauXDJIQhmGQ</id>
    <link href="https://mp.weixin.qq.com/s/xy9WjDonsUIauXDJIQhmGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有人@你，药物制剂前沿技术高峰论坛来了</title>
    <updated>2020-11-15T19:47:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/LB8_HDG1DONsg4IcdcbEnw</id>
    <link href="https://mp.weixin.qq.com/s/LB8_HDG1DONsg4IcdcbEnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人人学懂免疫学：第十一期</title>
    <updated>2020-11-15T19:47:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/H8Sw8Lixf92sFNTSLZAqZw</id>
    <link href="https://mp.weixin.qq.com/s/H8Sw8Lixf92sFNTSLZAqZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>HER2差异化: 他们不行，我行</title>
    <updated>2020-11-15T19:47:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/ZlS_7T9g3IyZ7qjRF34G6Q</id>
    <link href="https://mp.weixin.qq.com/s/ZlS_7T9g3IyZ7qjRF34G6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>